Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teladoc Health, Inc.
Report date September 04, 2024 · Filed September 05, 2024
Section 16 reporting ended · disclosed 2024-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,773 |
Reported balance
After 2024-09-04 transaction · row 1
1 source rowRow 1 · 2024-09-04 · Sale · Disposed 20,773 · Balance 20,773 F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2024 Filed Sep 5, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 20,773 | $7.26 | $150,811.98 |
DisclosureSEC source: 0001477449-24-000198 · wk-form4_1725566712.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,773 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,617 | $7.16 | $11,584.19 |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,546 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,602 Underlying: Common Stock · 3,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,696 Underlying: Common Stock · 1,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,341 Underlying: Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000186 · wk-form4_1725480694.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,627 | $11.16 | $18,152.44 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,659 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,702 Underlying: Common Stock · 3,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,044 Underlying: Common Stock · 1,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,397 Underlying: Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 16:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 43,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000072 · wk-form4_1710965460.xml · derivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,800 Underlying: Common Stock · 43,800 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,647 | $14.53 | $82,050.91 |
DisclosureSEC source: 0001477449-24-000051 · wk-form4_1709759110.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,782 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,190 | $14.52 | $89,854.04 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 8 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,429 F4 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 15 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F13 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 12,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 14 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,802 Underlying: Common Stock · 12,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F12 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F12 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 13 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,392 Underlying: Common Stock · 1,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 12 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F10 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F10 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 11 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F9 · derivative.exercise_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F9 · derivative.expiration_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 10 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,453 Underlying: Common Stock · 4,226 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F8 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F8 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 12,679 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · derivative · entry 9 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,679 Underlying: Common Stock · 12,679 shares Expires not disclosed F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F6 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. F7 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 7 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 12,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 6 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 5 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,226 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:08 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 475 | $15.06 | $7,153.50 |
DisclosureSEC source: 0001477449-24-000041 · wk-form4_1709672884.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,193 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 27, 2023. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 397 | $18.90 | $7,504.09 |
DisclosureSEC source: 0001477449-23-000099 · wk-form4_1701810338.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,668 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000099 · wk-form4_1701810338.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,740 Underlying: Common Stock · 1,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 16:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000099 · wk-form4_1701810338.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 16:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 396 | $22.89 | $9,066.02 |
DisclosureSEC source: 0001477449-23-000043 · wk-form4_1694031417.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,718 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000043 · wk-form4_1694031417.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,087 Underlying: Common Stock · 1,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000043 · wk-form4_1694031417.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 386 | $24.38 | $9,411.07 |
DisclosureSEC source: 0001415889-23-009203 · form4-06052023_080639.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,767 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009203 · form4-06052023_080639.xml · derivative · entry 3 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,434 Underlying: Common Stock · 1,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009203 · form4-06052023_080639.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 37,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004409 · form4-03072023_090301.xml · derivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,202 Underlying: Common Stock · 37,202 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 16:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,795 | $25.91 | $46,510.25 |
DisclosureSEC source: 0001415889-23-004409 · form4-03072023_090301.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,806 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 16 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437 Underlying: Common Stock · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F13 · derivative.exercise_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F13 · derivative.expiration_date: On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 874 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 15 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 874 Underlying: Common Stock · 874 shares Expires not disclosed F10 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. F12 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. F12 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 867 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 14 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 867 Underlying: Common Stock · 867 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 13 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,148 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 515 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 12 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F7 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F7 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 11 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,048 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis F6 · derivative.exercise_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F6 · derivative.expiration_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 10 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,205 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.